NCT04465669View on ClinicalTrials.gov

Heterogeneity of Neointimal Healing Following Biodegradable-polymer Drug-Eluting Coronary Stent Implantation

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 13, 2020

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2022

Conditions
Coronary Heart DiseaseStable Angina PectorisSilent Myocardial Ischemia
Interventions
DEVICE

Orsiro stents

"Percutaneous coronary intervention with implantation of either:~a Orsiro® biolimus a9 eluting coronary stent"

DEVICE

Resolute Integrity® stents

"Percutaneous coronary intervention with implantation of either:~a Resolute Integrity® zotarolimus eluting coronary stent"

Trial Locations (1)

625026

Tyumen Cardiology Research Center, Tomsk National Research Medical Center, Russian Academy of Science, Tyumen

All Listed Sponsors
lead

Tomsk National Research Medical Center of the Russian Academy of Sciences

OTHER

NCT04465669 - Heterogeneity of Neointimal Healing Following Biodegradable-polymer Drug-Eluting Coronary Stent Implantation | Biotech Hunter | Biotech Hunter